Kymera Therapeutics Announces Results From Its Phase 1 Study Of KT-621 In Healthy Japanese Adults Were Shared At The Japanese Dermatological Association Annual Meeting, June 11-14

뉴스 본문을 불러오고 있어요.

Kymera Therapeutics Announces Results From Its Phase 1 Study Of KT-621 In Healthy Japanese Adults Were Shared At The Japanese Dermatological Association Annual Meeting, June 11-14 | 웨이프 WAPE

Kymera Therapeutics Announces Results From Its Phase 1 Study Of KT-621 In Healthy Japanese Adults Were Shared At The Japanese Dermatological Association Annual Meeting, June 11-14

기사 요약

관련 종목

댓글 —